Nancy T. Rector
- Apr 8, 2019
- 1 min read

FDA approves first two-drug complete regimen for HIV-infected patients

who have never received anti retrovirus treatment.

https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm635526.htm?utm_campaign=040919_PR_FDA%20approves%20first%20two-drug%20complete%20regimen%20for%20HIV-infected%20patients&utm_medium=email&utm_source=Eloqua

Recent Posts

See All

Today's or Tonight's Tip

Johns Hopkins research focused on early stage bladder cancer wins $3.2 million federal grant

The new grant will support efforts by Johns Hopkins physician-scientists to participate in a novel multidisciplinary clinical trial for this cancer, called ADAPT-BLADDER for its ability to accomm

FDA approves new treatment for hospital-acquired and ventilator-associated bacterial pneumonia

The U.S. Food and Drug Administration today approved a new indication for the previously FDA-approved drug, Zerbaxa (ceftolozane and tazob